Out of 1,600 patients who had surgery for colorectal cancer, nearly 15 percent had pulmonary metastases within 15.4 months and higher-risk patients experienced lung metastases within three months, according to new research presented at the Scientific Forum of the American College of Surgeons Clinical Congress.
Emerging research suggests that more frequent chest imaging surveillance via computed tomography (CT) or positron emission tomography (PET) may be advantageous for high-risk patients who have undergone surgery for colorectal cancer.
Presenting the research at the Scientific Forum of the American College of Surgeons Clinical Congress in San Diego, the researchers noted they performed a retrospective review of data from 1,600 patients who had colorectal cancer. They found that 14.6 percent (233 patients) had pulmonary metastases within a median time of 15.4 months after colorectal surgery.
Using multivariate modeling, the study authors investigated clinical, pathologic, and genomic factors that were associated with a higher risk of pulmonary metastases.
“We found that patients with resectable colorectal cancer who required perioperative systemic therapy, who had an elevated lymph node ratio and a KRAS genetic mutation were at risk of developing a pulmonary metastasis within three months of their colorectal resection,” noted lead study author Nathaniel Deboever, M.D., who is a general surgery resident with the McGovern Medical School at the University of Texas Health Science Center in Houston. “This group of patients should have early post-colorectal cancer resection chest surveillance.”
Emphasizing the high incidence of lung metastases among people with colorectal cancer as well as an increasing incidence of colorectal cancer in younger adults, the study authors said there is an urgent need for evidence-based guidelines on the frequency and timing of chest CT or PET surveillance in high-risk patients.
“With this study, we sought to develop a strategy that is evidence-based to determine how frequently, at what intervals, and for how long patients at risk of developing lung metastases should undergo imaging of their chest,” added Mara Antonoff, M.D., FACS, an associate professor of thoracic and cardiovascular surgery at the University of Texas MD Anderson Cancer Center in Houston.
Based on their findings, the researchers recommended post-op surveillance chest imaging every three months for high-risk patients who have had colorectal resection surgery. They acknowledged that future research is necessary to validate their findings and potentially formalize standard chest imaging surveillance guidelines in these high-risk patient populations.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
GE HealthCare Launches PET MPI Agent Flyrcado at ACC Conference
March 28th 2025The positron emission tomography myocardial perfusion imaging (PET MPI) agent, which offers a significantly higher half-life than other cardiac PET agents, was recently granted pass-through payment status by CMS that will go into effect on April 1, 2025.